• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Medical Equipment/Devices
  • Sub-Industry: Life Science Equipment

Vermillion Inc

+ Add to Watchlist

CUL1:GR

1.679 EUR 0.084 4.76%

As of 09:34:50 ET on 07/28/2014.

Snapshot for Vermillion Inc (CUL1)

Open: 1.679 Day's Range: 1.679 - 1.679 Volume: 0
Previous Close: 1.763 52wk Range: 1.475 - 2.680 1-Yr Rtn: -21.40%

Stock Chart for CUL1

No chart data available.
  • CUL1:GR 1.679
  • 1D
  • 1M
  • 1Y
1.763
Interactive CUL1 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CUL1

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -
Est. PEG Ratio -
Market Cap (M EUR) 60.16
Shares Outstanding (M) 35.83
30 Day Average Volume 22
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/14/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CUL1

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CUL1

Vermillion, Inc. discovers, develops, and commercializes diagnostic tests. The Company focuses in the areas of oncology, hematology, cardiology, and women's health.

James T LafrancePresident/CEODonald G MunroeSenior VP:Business Dev
Marian E SaccoSenior VP:Sales/Chief Commercial OfcrEric J SchoenVP:Finance/Chief Acctg Ofcr/Controller
More Company Profile & Key Executives for CUL1

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil